Millennium Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Millennium Management’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-100,000	Closed	-$499K	–	6502
2025 Q3	$499K	Buy	+100,000	New	+$463K	﹤0.01%	5071
2019 Q1	–	Sell	-73,900	Closed	-$1.93M	–	4363
2018 Q4	$1.93M	Buy	73,900 +48,900	+196%	+$1.15M	﹤0.01%	2199
2018 Q3	$574K	Buy	+25,000	New	+$510K	﹤0.01%	3167
2013 Q4	–	Sell	-227,400	Closed	-$2.49M	–	3810
2013 Q3	$2.49M	Buy	227,400 +46,800	+26%	+$500K	0.01%	1548
2013 Q2	$1.46M	Buy	+180,600	New	+$1.22M	﹤0.01%	1767

Other funds holding VNDA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Millennium Management's VNDA Position: Q1 2026 in Review

Millennium Management increased its Vanda Pharmaceuticals (VNDA) stake by 12% in Q1 2026, buying an estimated $1.56M and bringing the position to 1,881,001 shares worth $13M. The position accounts for 0.01% of the portfolio, ranked #1923.

Millennium Management first reported a position in VNDA in Q2 2013 and has held it in 51 quarters since. The position peaked at $28M in Q3 2016. 170 funds tracked by Wall St. Rank hold VNDA as of Q1 2026.

Millennium Management held 1,881,001 shares of Vanda Pharmaceuticals worth $13M as of Q1 2026.
Millennium Management bought 201,988 Vanda Pharmaceuticals shares in Q1 2026, an estimated $1.56M.
Vanda Pharmaceuticals made up 0.01% of Millennium Management's portfolio in Q1 2026, its #1923 holding.
Millennium Management first reported a position in Vanda Pharmaceuticals in Q2 2013 and has held it in 51 quarters since.
Millennium Management's Vanda Pharmaceuticals position peaked at $28M in Q3 2016.
170 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.